Dr. Reddy’s Laboratories shares to go ex-dividend tomorrow. Do you own?

Synopsis

Investors seeking Dr. Reddy’s Laboratories' final dividend of Rs 8 per share for FY25 must purchase shares by today, July 9, as it is the last day to qualify. The record date is set for July 10, 2025, and settlement timelines require purchases before the ex-dividend date. On Tuesday, Dr. Reddy’s shares closed 2% lower at Rs 1,283.

Shares of Dr Reddy’s Laboratories are in focus on Wednesday, July 9, as today marks the last trading day for investors to buy the stock in order to qualify for the company’s final dividend of Rs 8 per share for the financial year ended March 31, 2024 (FY25).

The pharmaceutical major had earlier announced a final dividend of Rs 8 per equity share of face value Re 1 each.

“We would like to inform you that the Board of Directors of the Company, at their meeting held on May 9, 2025, has inter alia transacted and approved the following businesses: Recommended a final dividend of Rs. 8/- per equity share of Rs. 1/- each for the financial year 2024-25,” the company said in a previous filing to the stock exchanges.

The record date for the dividend has been set as Wednesday, July 10, 2025. This means that investors who want to receive the dividend must purchase the shares before the ex-dividend date, which is today.

Under standard settlement timelines followed by Indian stock exchanges, trades take two working days (T+1) to settle. Therefore, only those shareholders whose names appear in the company’s register of members as of the record date — July 10 — will be eligible to receive the dividend.

To ensure that the shares are credited in time, investors must buy Dr Reddy’s shares no later than July 9. Therefore, investors eyeing the dividend benefit must ensure to complete their purchase of Dr Reddy’s shares before the market closes today.

The shares of Dr. Reddy’s Laboratories closed 2% lower at Rs 1,283.90 on the BSE on Tuesday.

(Disclaimer: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of The Economic Times)

...moreless

...moreless